Molecules · 2014 · 18 citations · 33 references
PharmacyMedicinal ChemistryPharmacologyDrug DiscoveryEnzymologySynthetic Medicinal ChemistryAntibacterial PharmacologyDrug-metabolizing EnzymesEnzyme FunctionEnzyme InhibitionLigand-based DesignAntibiotic DiscoveryBidentate Ligand BindingEnzyme Target AffinityMedicinal Chemistry ApplicationsNovel Antibacterial Drug DiscoveryPlasmodium FalciparumTarget Enzyme Inhibition
Fourteen new fosmidomycin analogues with altered metal chelating groups were prepared and evaluated for inhibition of E. coli Dxr, M. tuberculosis Dxr and the growth of P. falciparum K1 in human erythrocytes. None of the synthesized compounds showed activity against either enzyme or the Plasmodia. This study further underlines the importance of the hydroxamate functionality and illustrates that identifying effective alternative bidentate ligands for this target enzyme is challenging.
33
The global distribution of clinical episodes of Plasmodium falciparum malaria
Robert W. Snow, Carlos A. Guerra, Abdisalan M. Noor et al. · Nature · 2005 · 2.7K citations · Full text
Veterinary Medicine, Health Sciences, Infectious Diseases +14
Inhibitors of the Nonmevalonate Pathway of Isoprenoid Biosynthesis as Antimalarial Drugs
Hassan Jomaa, Jochen Wiesner, Silke Sanderbrand et al. · Science · 1999 · 1.2K citations